Serina Therapeutics, Inc. 8-K

What Happened

• Serina Therapeutics (SER) filed an 8-K on July 23, 2026 reporting an Amended and Restated Employment Agreement with CEO Steve Ledger dated July 19, 2026. The agreement updates and replaces the prior employment agreement from September 9, 2024 and sets Mr. Ledger’s annual base salary at $500,000 and a target annual bonus equal to 50% of base pay.

Key Details

• Base salary: $500,000 per year; target bonus: 50% of base salary, based on Board-set goals.
• Standard severance (termination by company without Cause or resignation for Good Reason, not in connection with a Change in Control): 12 months of base salary plus a pro‑rated annual bonus, paid in a lump sum within 60 days, and COBRA premium reimbursement for up to 12 months (subject to release).
• Change-in-control qualifying termination (termination without Cause or for Good Reason within 3 months before to 12 months after a Change in Control): 1.5× base salary, 1.5× target bonus, pro‑rated bonus, lump-sum payment within 60 days, COBRA for up to 18 months, and full accelerated vesting of then‑unvested time‑based equity awards.
• Equity: confirms previously granted stock options, allows Board discretion to grant additional equity, and requires outstanding awards to be assumed/substituted by a successor in a Change in Control. Section 280G “parachute” payments are subject to a best‑net reduction (no excise tax gross‑up). Agreement includes confidentiality, a two‑year non‑compete, 18‑month non‑solicit/no‑hire, and non‑disparagement covenants.

Why It Matters

• This filing shows the company has formalized retention and severance protections for its CEO, which can affect Serina’s cash obligations and potential equity dilution if accelerated vesting occurs after a change in control. The 1.5× Change‑in‑Control payouts and accelerated vesting are standard protections for executives but could increase costs and share issuance in a sale or merger. The absence of a tax gross‑up for 280G payments indicates the company is limiting long‑term tax liabilities tied to executive payouts.